Schwann cell

Updated: 2026-08-14

Overview

Schwann cells are specialized glial cells exclusive to the peripheral nervous system (PNS), named after the physiologist Theodor Schwann. They are pivotal in forming the myelin sheath around axons, which accelerates electrical impulse transmission. Unlike oligodendrocytes in the central nervous system (CNS), each Schwann cell myelinates a single axon segment. These cells also contribute to nerve regeneration by creating a supportive microenvironment post-injury. Their ability to clear cellular debris and secrete growth factors makes them a focus of research in neurodegenerative diseases and trauma recovery. In vitro, Schwann cells are used to study myelination mechanisms and test potential therapies.

Key Features

Schwann cells exhibit unique plasticity, enabling them to dedifferentiate into a repair phenotype after nerve damage. This adaptability facilitates axon regrowth by producing extracellular matrix proteins and neurotrophic factors like NGF and BDNF. Their myelination capability is selective; non-myelinating Schwann cells support smaller axons by bundling them into Remak fibers. Electrophysiological studies highlight their role in maintaining saltatory conduction, which is critical for efficient neural communication. Recent advances in single-cell RNA sequencing have unveiled subtype diversity, opening new avenues for targeted therapies.

Application Areas

In regenerative medicine, Schwann cells are harnessed for nerve graft engineering. Autologous transplants show promise in treating peripheral nerve injuries, such as brachial plexus damage. Combined with biomaterial scaffolds, they enhance functional recovery in preclinical models. Pharmaceutical companies utilize Schwann cell cultures to screen drugs for neuropathic pain or Charcot-Marie-Tooth disease. Their role in tumor microenvironments, particularly in schwannomas, is another active research area. Biotechnology firms supply primary and immortalized cell lines for academic and industrial labs.

Precautions

Working with Schwann cells demands stringent aseptic techniques to avoid microbial contamination, which can alter cell behavior. Cryopreserved batches should be thawed rapidly and cultured in specialized media containing heregulin or forskolin to maintain phenotype. Ethical sourcing is critical—primary cells from human donors require IRB approval. Researchers must validate cell identity via markers like S100β or GFAP. Prolonged passaging can reduce myelination capacity, so early-passage cells are preferred for functional assays.

B2B Procurement Guide

When procuring Schwann cells, prioritize suppliers with ISO certification and batch-specific CoAs detailing viability (>90%), mycoplasma testing, and purity (≥95% S100β-positive). Custom isolation services from donor tissue (e.g., rodent sciatic nerves) are available for specialized projects. Bulk orders may qualify for discounts; some vendors offer pre-myelinating co-culture systems with neurons. For translational research, consider GMP-grade cells compliant with FDA/EMA regulations. Lead times vary—stock cultures ship within days, while custom preparations may take weeks.